LISINOPRIL/HYDROCHLOROTHIAZIDE ZENTIVA 20 mg/12,5 mg, comprimé sécable — plaquette(s) PVC PVDC aluminium de 90 comprimé(s)
Conditionnement de médicament · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400937874892 -
CIP7
3787489 -
CIS
67874804
Ce que publie la source
- Titulaire
- ZENTIVA FRANCE
- Substances actives
- HYDROCHLOROTHIAZIDE, LISINOPRIL ANHYDRE, LISINOPRIL DIHYDRATÉ
- Forme
- comprimé sécable
- Conditionnement
- plaquette(s) PVC PVDC aluminium de 90 comprimé(s)
- Voies d’administration
- orale
- Statut administratif
- authorised
- Régime de délivrance
- liste I
- Statut de commercialisation
- Déclaration de commercialisation
- Date d’autorisation
- 2006-02-08
- Prescription
- Sur ordonnance ou à délivrance restreinte
Noms permettant de trouver cette fiche
- LISINOPRIL/HYDROCHLOROTHIAZIDE ZENTIVA 20 mg/12,5 mg, comprimé sécable — plaquette(s) PVC PVDC aluminium de 90 comprimé(s)
- LISINOPRIL/HYDROCHLOROTHIAZIDE ZENTIVA 20 mg/12,5 mg, comprimé sécable
- HYDROCHLOROTHIAZIDE
- LISINOPRIL ANHYDRE
- LISINOPRIL DIHYDRATÉ
Données complètes de la source
{
"cis": "67874804",
"cip7": "3787489",
"form": "comprimé sécable",
"name": "LISINOPRIL/HYDROCHLOROTHIAZIDE ZENTIVA 20 mg/12,5 mg, comprimé sécable — plaquette(s) PVC PVDC aluminium de 90 comprimé(s)",
"cip13": "3400937874892",
"holder": "ZENTIVA FRANCE",
"routes": [
"orale"
],
"holders": [
"ZENTIVA FRANCE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "13.61",
"authorisedOn": "2006-02-08",
"compositions": [
{
"name": "HYDROCHLOROTHIAZIDE",
"nature": "SA",
"strength": "12,5 mg",
"linkageNumber": "2",
"substanceCode": "02064",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "LISINOPRIL ANHYDRE",
"nature": "FT",
"strength": "20 mg",
"linkageNumber": "1",
"substanceCode": "15304",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "LISINOPRIL DIHYDRATÉ",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "60255",
"dosageReference": null,
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "2.76",
"medicinePrice": "10.85",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "LISINOPRIL/HYDROCHLOROTHIAZIDE ZENTIVA 20 mg/12,5 mg, comprimé sécable",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) PVC PVDC aluminium de 90 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65 %"
],
"marketingDeclaredOn": "2023-06-30",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"HYDROCHLOROTHIAZIDE",
"LISINOPRIL ANHYDRE",
"LISINOPRIL DIHYDRATÉ"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Lisez cette fiche depuis votre propre logiciel
La même fiche, avec tous ses champs et sa provenance, est à portée d’une requête. Une clé API est gratuite et fonctionne immédiatement.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400937874892"